SensoDetect Aktiebolag Stock

Equities

SDET

SE0003037456

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET 06:00:00 2024-01-30 pm EST 5-day change 1st Jan Change
0.117 SEK -2.50% Intraday chart for SensoDetect Aktiebolag -.--% -48.00%
Sales 2021 2.58M 235K Sales 2022 820K 74.49K Capitalization 36.86M 3.35M
Net income 2021 -7M -636K Net income 2022 -8M -727K EV / Sales 2021 20.2 x
Net cash position 2021 1.89M 172K Net cash position 2022 660K 59.96K EV / Sales 2022 44.1 x
P/E ratio 2021
-6.73 x
P/E ratio 2022
-4.07 x
Employees 2
Yield 2021 *
-
Yield 2022
-
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
SensoDetect Aktiebolag Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
SensoDetect Aktiebolag Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
SensoDetect Aktiebolag Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
SensoDetect Aktiebolag Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
SensoDetect Aktiebolag Auditor Raises 'Going Concern' Doubt CI
SensoDetect Aktiebolag Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 CI
SensoDetect Aktiebolag Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
SensoDetect Aktiebolag Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
SensoDetect Aktiebolag Auditor Raises 'Going Concern' Doubt CI
SensoDetect Aktiebolag Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
SensoDetect Aktiebolag Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021 CI
SensoDetect Aktiebolag Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Sensodetect Aktiebolag Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Sensodetect Aktiebolag Reports Earnings Results for the Full Year Ended December 31, 2020 CI
SensoDetect Aktiebolag Auditor Raises 'Going Concern' Doubt CI
More news
1 day-2.50%
3 months-5.65%
6 months-67.23%
Current year-48.00%
More quotes
Current year
0.11
Extreme 0.109
0.29
1 year
0.10
Extreme 0.095
0.70
3 years
0.10
Extreme 0.095
0.93
5 years
0.10
Extreme 0.095
1.85
10 years
0.10
Extreme 0.095
18.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO 63 -
Corporate Officer/Principal - -
Members of the board TitleAgeSince
Director/Board Member 65 -
Chairman 57 -
Director/Board Member - 19-05-01
More insiders
SensoDetect AB is a Sweden-based company within healthcare sector. Its primary product SensoDetect BERA is a tool for investigation of brainstem function. It measures brainstem activity and provides brainstem audiometry measuring the brain’s response to sound. Brainstem audiogram of a patient is compared to the ones of healthy persons and discrepancy areas are related to psychiatric diagnoses schizophrenia and attention deficit hyperactivity disorder (ADHD). The product is designed for such areas as psychiatry, pharmaceutical industry and research. The Company’s primary markets comprise the United Kingdom, Germany, Sweden and Bolivia. The main shareholders are Avanza Pension and Nordnet Pensionsforsakring.
More about the company

Annual profits - Rate of surprise